AP NEWS
This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Globe Newswire
This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation.

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of STMP, DPLO, BPI and USX

March 11, 2019

NEW YORK, March 11, 2019 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Stamps.com Inc. (NASDAQ: STMP) Class Period: May 3, 2017 to February 21, 2019 Lead Plaintiff Deadline: April 29, 2019

The lawsuit alleges that throughout the class period, Stamps.com Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the Company’s financial results depended on the manipulation of a USPS program that cost USPS an estimated $235 million per year; and (ii) as a result, the Company’s business was unsustainable and its financial results were highly misleading.

Get additional information about the STMP lawsuit: http://www.kleinstocklaw.com/pslra-1/stamps-com-inc-loss-submission-form?wire=3

Diplomat Pharmacy, Inc. (NYSE: DPLO) Class Period: February 26, 2018 to February 21, 2019 Lead Plaintiff Deadline: April 25, 2019

The lawsuit alleges Diplomat Pharmacy, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) Diplomat had downplayed its success in integrating and growing its PBM business, which included LDI Integrated and National Pharmaceutical, two companies Diplomat had acquired in late 2017; (2) consequently, Diplomat would need to record a non-cash impairment charge upwards of approximately $630 million relating to its PBM business and these 2017 acquisitions; (3) due to the foregoing, Diplomat would withdraw its preliminary 2019 full-year outlook issued less than seven weeks prior; and (4) as a result, defendants’ statements about Diplomat’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Get additional information about the DPLO lawsuit: http://www.kleinstocklaw.com/pslra-1/diplomat-pharmacy-inc-loss-submission-form?wire=3

Bridgepoint Education Inc. (NYSE: BPI) Class Period: March 8, 2016 to March 7, 2019 Lead Plaintiff Deadline: May 10, 2019

The complaint alleges that throughout the class period Bridgepoint Education Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Bridgepoint’s processes for recording revenue for its FTG program were inaccurate; (ii) Bridgepoint maintained deficient internal controls; (iii) due to the foregoing deficiencies, Bridgepoint was prone to and did commit material accounting errors related to revenue, provision for bad debts, accounts receivable and deferred revenue, which resulted in the overstatement of revenue and expenses; and (iv) as a result, Bridgepoint’s public statements were materially false and misleading at all relevant times.

Get additional information about the BPI lawsuit: http://www.kleinstocklaw.com/pslra-1/bridgepoint-education-inc-loss-submission-form?wire=3

U.S. Xpress Enterprises, Inc. (NYSE: USX) Class Period: Purchasers of common stock pursuant/and or traceable to the initial public offering completed in June 2018 Lead Plaintiff Deadline: May 10, 2019

The complaint alleges that the Offering Documents failed to disclose that: (1) a shortage of trucks was negatively impacting U.S. Xpress’s dedicated division; (2) (a) certain shipping patterns had been performing differently than expected and, as a result, (b) utilization and driver retention and hiring were being negatively affected, and as a result, (c) U.S. Xpress’s dedicated accounts, including one large account, were being negatively impacted; and as a result, (d) U.S. Xpress’s OTR division was providing continued support to the dedicated division; (3) (a) U.S. Xpress failed to stay informed regarding two large liability events; and as a result (b) U.S. Xpress’s insurance claim expense was understated; and (4) U.S. Xpress’s cost per mile for driver wages and independent contractors was exceeding the Company’s internal expectations.

Get additional information about the USX lawsuit: http://www.kleinstocklaw.com/pslra-1/u-s-xpress-enterprises-inc-loss-submission-form?wire=3

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:J. Klein, Esq.Empire State Building350 Fifth Avenue59th FloorNew York, NY 10118 jk@kleinstocklaw.com Telephone: (212) 616-4899Fax: (347) 558-9665www.kleinstocklaw.com